When a woman is diagnosed with atypical endometrial hyperplasia or early endometrial carcinoma, the path forward can feel overwhelming. These are conditions where the lining of the uterus shows abnormal cell growth that could lead to cancer. Doctors often have to decide between immediate surgery and more conservative management.
A review of data from 846 women suggests that a longer period of conservative treatment—lasting more than 12 months—might be an option for some patients. In this group, about 58% of those on the longer plan saw a complete response. However, others faced different outcomes: 33% experienced a recurrence of their condition, and 26% had a poor response to treatment.
It is important to note that while these results show a possible path for some, the evidence is still considered weak. Because the data comes from a pooled set of studies, it may not apply to everyone. This approach would only be considered for carefully selected patients who are monitored very closely by their doctors.
